Supplementary Figure 4 from Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8&lt;sup&gt;+&lt;/sup&gt; T Lymphocytes